Who owns URGNWhat URGN owns — n/a

Who owns UroGen Pharma Ltd.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of URGN from SEC Form 13F filings across 158 reporting managers. All positions are from one synchronized reporting period — 2026-03-31 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-03-31 reporting period, 158 institutions disclosed 54.3M shares of UroGen Pharma Ltd. worth $881.6M; the largest disclosed holder is RTW INVESTMENTS, LP. Source: SEC Form 13F filings, parsed by EvidInvest.

158

13F holders

$881.6M

value, 2026 filers

54.3M

shares disclosed

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-03-31 · % of fund = share of the manager's own book · % of co. = share of URGN's shares outstanding

#	Manager	Shares	Value	% of fund	% of co.	Δ shares QoQ
1	RTW INVESTMENTS, LP	4.5M	$81.7M	0.8%	—	—
2	BlackRock, Inc.	2.8M	$51.2M	0.0%	—	—
3	QUADRANT CAPITAL GROUP LLC	688	$49.0M	0.0%	—	—
4	TORONTO DOMINION BANK	2.6M	$47.0M	0.1%	—	—
5	MORGAN STANLEY	2.6M	$46.0M	0.0%	—	—
6	Kynam Capital Management, LP	2.2M	$40.4M	2.5%	—	—
7	Jefferies Financial Group Inc.	2.2M	$39.5M	0.3%	—	—
8	ProQuest Associates IV LLC	789,297	$37.3M	70.4%	—	—
9	BlackRock Inc.	2.2M	$36.8M	0.0%	—	—
10	Paradigm Biocapital Advisors LP	1.7M	$30.6M	0.6%	—	—
11	ACORN CAPITAL ADVISORS, LLC	1.7M	$30.1M	8.6%	—	—
12	SG Americas Securities, LLC	1.7M	$29.8M	0.0%	—	—
13	AMERICAN CENTURY COMPANIES INC	1.6M	$29.4M	0.0%	—	—
14	SILVERARC CAPITAL MANAGEMENT, LLC	1.5M	$27.0M	2.8%	—	—
15	Opaleye Management Inc.	1.4M	$25.7M	3.4%	—	—
16	FRONTIER CAPITAL MANAGEMENT CO LLC	1.3M	$23.6M	0.2%	—	—
17	COWEN AND COMPANY, LLC	1.8M	$22.8M	0.8%	—	—
18	MENORA MIVTACHIM HOLDINGS LTD.	1.2M	$20.7M	0.1%	—	—
19	D. E. Shaw & Co., Inc.	1.0M	$18.4M	0.0%	—	—
20	CREDIT SUISSE AG/	1.2M	$18.0M	0.0%	—	—
21	BioImpact Capital LLC	943,803	$17.0M	1.3%	—	—
22	J. Goldman & Co LP	938,870	$16.9M	0.5%	—	—
23	ORBIMED ADVISORS LLC	875,487	$15.7M	0.3%	—	—
24	STATE STREET CORP	874,176	$15.7M	0.0%	—	—
25	Delek Group, Ltd.	408,303	$14.3M	0.6%	—	—

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.